Drug intelligence / Profile preview

MCMV-B5

Development stage
Preclinical
Lead developer
Lions Eye Institute
Modality
Vaccines & Immunotherapeutics
Administration
Intraperitoneal
01

Overview

MCMV-B5 is a preclinical recombinant murine cytomegalovirus (MCMV) viral vector vaccine candidate designed to boost and prolong immunity against malaria. It is engineered to express the *Plasmodium chabaudi* merozoite surface protein 1 (MSP-1) CD4+ T-cell epitope B5. Developed by researchers at Rutgers New Jersey Medical School, the University of Texas Medical Branch, and collaborating institutions, MCMV-B5 acts as a booster to live malaria vaccines. It functions by stimulating and maintaining parasite-specific effector T cells (Teff) and effector memory T cells (Tem), while the MCMV vector itself provides non-specific adjuvant properties through prolonged stimulation of interferon-gamma (IFN-γ).

Other names
murine cytomegalovirus encoding P. chabaudi MSP-1 epitope B5murine cytomegalovirus encoding Plasmodium chabaudi MSP-1 epitope B5
02

Targets

MSP1 (Merozoite surface protein 1)

Beyond the preview

Go deeper on MCMV-B5.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MCMV-B5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call